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Genetic mutations in plectin, a cytoskeleton linker
protein expressed in a large variety of tissues including
skin, muscle, and nerves, cause epidermolysis bullosa
simplex with muscular dystrophy, a recessive inherited
disease characterized by blistering of the skin and
late onset of muscular dystrophy, and Ogna epider-
molysis bullosa simplex, a rare dominant inherited
form of epidermolysis bullosa simplex with no muscu-
lar involvement. Here we report a novel homozygous
genetic mutation (2727del14) in the plectin gene
(PLEC1) associated with a lethal form of recessive
inherited epidermolysis bullosa in a consanguineous
family with three a¡ected o¡spring. This new clinical
variant of epidermolysis bullosa is characterized by
general skin blistering, aplasia cutis of the limbs, devel-
opmental complications, and rapid demise after birth.
Mutation 2727del14 is the ¢rst genetic defect described
in PLEC1 that disrupts the plakin domain of plectin.
The severe phenotype of the patients may be linked to
the role of the N-terminal domain in the function
of plectin and develops the understanding of the
genotypephenotype correlations in the genoderma-
toses a¡ecting the dermalepidermal junction. Key
words: basement membrane/dermalepidermal junction/
PLEC1/skin blistering disease. J Invest Dermatol 121:1344 ^
1348, 2003
P
lectin is a widely expressed cytomatrix component in-
volved in the attachment of the cytoskeleton to the
plasma and nuclear membrane (Wiche, 1998).This high
molecular weight protein (4500 kDa), which exists in
several isoforms, interacts with a variety of intermedi-
ate ¢lament proteins and assures the interlinking of intermediate
¢laments with microtubules and micro¢laments, and also binds
to a-spectrin, nuclear lamin B (Foisner et al, 1991; Svitkina et al,
1996). Plectin also constitutes a substrate for caspase 8 during
CD95 and tumor necrosis factor receptor mediated apoptosis
(Stegh et al, 2000). In the skin, plectin localizes both within the
hemidesmosomes, where it associates with the cytokeratin ¢la-
ments and the cytoplasmic domains of integrin b4 and collagen
XVII, and in the desmosomes, where it interacts with desmopla-
kin and the actin ¢laments (Eger et al, 1997; Rezniczek et al, 1998;
Koster et al, 2003). In skeletal muscle, plectin is found in the
sarcolemma and in the Z-line structures, and colocalizes with the
intermediate ¢lament protein desmin (Gache et al, 1996). In addition
to skin and skeletal muscle, plectin is abundantly expressed in a
variety of tissues, including the brain and cardiac muscle, where
the protein is detected in the intercalated discs (Andra et al, 1997).
Genetic mutations in the gene (PLEC1) plectin cause epider-
molysis bullosa simplex with muscular dystrophy (EBS-MD)
(OMIM #226670), which is a rare autosomal recessive disease
characterized by generalized blistering of the skin associated with
muscular involvement (Chavanas et al, 1996; Smith et al, 1996;
Uitto et al, 1996). Blistering occurs especially on ¢ngers and feet,
but can also develop on the scalp, face, and trunk following phy-
sical trauma. Mucosal involvement with blistering and erosions
may result in scarring of the oropharyngeal tract. Nail dystrophy
develops with age, and symblepharon (adhesion of the eyelids to
the eyeball), urethral stricture, laryngeal webs, brain atrophy, and
infantile respiratory complications have also been reported (Ichiki
et al, 1987; Mellerio et al, 1997; Fine et al, 2000). Late-onset muscu-
lar dystrophy characterized by progressive muscle weakness is also
part of the syndrome (Fine et al, 2000). In the patients a¡ected by
this uncommon form of EBS, skin blisters arise by a low level
splitting of the basal keratinocytes. The separation between der-
mis and epidermis occurs just above the hemidesmosomes, which
are dissociated from the keratin ¢laments and remain attached to
the lamina densa of the dermalepidermal junction, which sug-
gests a defective anchorage of the cytoskeletal structures to the
inner plaque of the hemidesmosome. Immunohistochemical ana-
lysis of the skin and muscles of EBS-MD patients demonstrates
negative staining with antibodies directed against plectin,
whereas all the other known proteins of the dermalepidermal
junction are reactive (Gache et al, 1996). A genetic mutation in
PLEC1 has also been associated with the dominant inherited
form of EBS-Ogna (EBS-O, OMIM 131950), in which muscular
symptoms are absent (Koss-Harnes et al, 2002).
The numerous abnormalities associated with EBS-MD re£ect
the functional complexity of plectin, and the importance of this
molecule has been con¢rmed in plectin knock-out mice, which
show lethal severe skin blistering and skeletal and muscle anoma-
lies (Andra et al, 1997). The genetic mutations so far identi¢ed in
EBS patients with associated late onset MD consist of insertions
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or deletions of nucleotides, which result in the synthesis of aber-
rant plectin RNA transcripts bearing a shift in the open reading
frame and/or a premature termination codon (PTC), whereas
EBS-O is associated with an amino acid substitution in the rod
domain of the protein. In this study, we identi¢ed a genetic mu-
tation in the PLEC1 gene in two related patients presenting a se-
vere form of EBS causing demise immediately after birth, and
reminiscent of the severe phenotype of EBS-MD described in
the plectin-null mice. Further, this study indicates the importance
of the plakin domain in the functionality of the protein.
MATERIALS AND METHODS
Clinical features The three probands were sisters and products of a
consanguineous union between cousins in a Turkish family. In another
kindred with eight una¡ected children, and closely related to the
probands’ family, two cases with similar clinical manifestations were
stillborn. During the ¢rst pregnancy a polymalformative fetus was
diagnosed at 34 wk with £exion contractures of the upper and lower
limbs. After amniotic £uid punction for evacuation of the poly-
hydramnios and rupture of the membranes, a premature female infant of
1450 g was born. The infant (proband 1) had a dysmature aspect with a
relative macrocephaly, deep-set eyes, hypoplastic ears with helices fused
with the skin of the skull, and an upturned hypoplastic nose. Fingers and
toes were in hyperextension. The karyotype was normal. Clinical
examination revealed absence of the skin (aplasia cutis congenita) on the
nose, the neck, the buttocks, and the distal parts of the extremities.
Remarkable skin fragility was noted as well as involvement of the oral
mucosa. The infant died a few hours after birth. During the second
pregnancy the mother was followed by ultrasound examinations, which
appeared normal until the twenty-third week of pregnancy. At the
twenty-eighth week of gestation, sonographic images were suggestive of
cutaneous desquamation, blister formation, and obstruction of the gastric
outlet, which raised the hypothesis of epidermolysis bullosa with pyloric
atresia (Gache et al, 1998). For religious reasons the mother refused
termination of the pregnancy and at 34 wk she delivered a female newborn
of 1540 g (proband 2). Proband 2 had similar dysmorphic features and an
even more profound involvement of the extremities with aplasia cutis at the
distal parts with an abrupt transition from normal to abnormal areas and
visualization of the underlying muscle layer. Upper extremities were in
¢xed extension and lower extremities in ¢xed £exion. This child also died a
few hours after birth, and skin samples were taken immediately after demise.
For religious reasons, the parents did not allow either photographic
documentation of the case or necroscopy; therefore occurrence of pyloric
atresia and possible involvement of muscular tissue were not substantiated.
Despite intensive counseling, a third pregnancy was started, which produced
another a¡ected fetus. The pregnancy was ended at 31.5 wk gestation after
agreement with termination. The fetus showed clinical ¢ndings similar to
probands 1 and 2. No biologic samples were obtained from proband 3. The
experiments were conducted with the informed consent of the patients
family and with the approval of the ethical committee of Nice University
Hospital in accordance with the Helsinki Principles.
Immunohistochemistry Indirect immuno£uorescence analysis of
frozen skin samples was performed as previously described (Gache et al,
2001). Immunomapping of the hemidesmosome components was
performed using the monoclonal antibody (mAb) HD121 directed against
plectin (Hieda et al, 1992); mAb GoH3 against integrin a6 (Sonnenberg
et al, 1987); mAb 3E1 against integrin b4 (Gibco BRL Life Technologies,
Cergy Pontoise, France); polyclonal antibody FP1 and mAb 233, speci¢c
to bullous pemphigoid antigens BP230 (Tanaka et al, 1990) and collagen
XVII (Nishizawa et al, 1993), respectively. Expression of laminin 5 was
investigated using mAb GB3 raised against the native laminin 5
(Verrando et al, 1991), that of collagen type VII using mAb LH7:2
(Cymbus Biotechnology, Chandlers Ford, UK) and that of cytokeratin 14
using mAb CKB1 (Sigma-Aldrich, Lyon, France). Secondary antibodies
were £uorescein isothiocyanate conjugated goat antimouse Ig (Dako,
Trappes, France), goat antirat IgG (Cappel, ICN Biomedicals, Orsay,
France), or swine antirabbit Ig (Dako). The tissue sections were analyzed
using an epiluminescence Zeiss Axiophot microscope.
Detection of the genetic mutation Genomic DNA (gDNA) was
obtained from two probands and their immediate family members,
and from an unrelated healthy individual, which served as a control.
PCR ampli¢cation of exonic sequences of the PLEC1 gene (GenBank
U53834, U63609, U63610) was performed using primers located in
£anking introns. The resulting PCR products were subjected to hetero-
duplex analysis by conformation sensitive gel electrophoresis (CSGE)
(Ganguly et al, 1993). The PCR products exhibiting heteroduplexes by
CSGE were further analyzed by direct automated DNA sequencing using
an ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA).
The primers used for the PCR ampli¢cation of exon 22 to detect mutation
2727del14 were as follows: 22L, 50 -TAAGCAGGTGGAGGTGAGTG-30,
and 22R, 50 -CAGGTCAGGGCTACAGTCAG-30. The PCR cycling
conditions were: 951C, 5 min, 951C, 30 s, 601C, 30 s, 721C, 40 s, for 35
cycles, followed by an extension of 721C for 7 min, using 100 ng of gDNA
in a standard PCR. The mutation was veri¢ed by restriction enzyme
digestion of the PCR products, using primer 21L 50 -TACCTCCTGC-
TTCCAAGTGC-30 and 22R, according to the manufacturer’s recommen-
dations (New England Biolabs, Beverly, MA).
RESULTS AND DISCUSSION
The clinical observations of the a¡ected newborns and poly-
hydramnios during gestation were consistent with the notion of
inherited epidermolysis bullosa with pyloric atresia (Gache et al,
1998; Fine et al, 2000). Indirect immuno£uorescence analysis of
frozen samples of the probands’ skin was performed using a panel
of antibodies directed against the known protein components
in the basement membrane of the dermalepidermal junction.
Due to the severity of the lesions and the uncooperative attitude
of the family, it was not possible to obtain samples of nonin-
volved skin; therefore histology and immunohistochemistry
were performed on blistered integument. Histologic examination
revealed that the epithelial layers were missing (not shown).
Immuno£uorescence staining of horizontal sections of the
probands’ dermis revealed that the basal cytokeratins and the
basement membrane proteins of the skin annexes were immu-
noreactive to all the antibodies except the antiplectin mAb
HD121 (Fig 1a). PLEC1was therefore designated as the candidate
gene for the mutation in the two probands. In vertical sections,
reactivity of bullous pemphigoid antigen BP230 (not shown),
collagen type XVII, integrin a6b4, and cytokeratin 14 (Fig 1c, e,
g) was reduced compared with controls (Fig 1d, f, h). The im-
mune reactive epitopes localized at the £oor of the blistered skin,
which indicated a localization of the cleavage plane within the
low ventral side of the basal keratinocytes. The clinical and im-
munohistologic observations therefore appeared consistent with
the diagnosis of EBS caused by an impaired expression of plectin
(Gache et al, 1996).
Because plectin cDNA could not be obtained by RT-PCR am-
pli¢cation of the messenger RNA extracted from the probands’
skin biopsies, mutation analysis was initiated by PCR ampli¢ca-
tion of exonic sequences in the gene PLEC1, followed by hetero-
duplex analysis using CSGE (Ganguly et al, 1993). Analysis of the
DNA segment encoding the plakin domain of plectin was unu-
sually complex in this epidermolysis bullosa family. PCR ampli-
¢cation of exon 20 was unsuccessful when the gDNA of the
mother and two probands was used as a template, whereas in the
father and control a 317 bp ampli¢cation product was obtained
(not shown). Subsequent PCR ampli¢cation experiments per-
formed with primer sets speci¢c to genomic DNA regions inclu-
sive of exons 20^22 ampli¢ed a 1552 bp DNA fragment in the
mother and probands, and an additional 1665 bp DNA fragment
in the father that co-migrated with the single PCR product ob-
tained from ampli¢cation of the control DNA (Fig 2A). Because
of the consanguinity of the parents, the identical migration pro-
¢le of the DNA fragments in the mother (presumed a heterozy-
gous healthy carrier) and the probands (assumed homozygous for
the morbid PLEC1 allele) was puzzling. In addition, the migra-
tion pro¢le in the father showed similarity to that of the wild-
type control. To clarify these unusual ¢ndings, we restricted the
analysis to the PCR products obtained from ampli¢cation of
exons 21 and 22. By agarose gel analysis the size of this fragment
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in the two probands, the parents, and the control sample appeared
to be the expected 606 bp, but CSGE analysis revealed a complex
pattern of shifts in the migrating bands compared to a healthy
control, and also indicated that the parents are heterozygous
(Fig 2B). Additional minor and slow migrating bands were
detected in the father. Sequencing of the 1665 and the 606 bp PCR
products from each of the family members, and comparison with
the control, resulted in the identi¢cation of four distinct DNA
sequence anomalies in the £anking intronic sequence of exons
20 and 21 (arbitrarily designated as A, B, C, D in Fig 2D), and a
sequence variation (M in Fig 2D) in exon 22. Variation M con-
sists of a deletion of 14 nucleotides homozygous in both probands
and heterozygous in the parents (Fig 2C). The deletion occurs in
a sequence where a 5 bp segment repeat (CCAGG, at positions
2727^2731 and 2741^2745 of the plectin cDNA sequence, Gene-
bank no. U53204) £anks a unique 9 bp sequence AGGCCGTCA
at positions 2732^2740. Interestingly, this exonic sequence varia-
tion, designated 2727del14 (Beaudet and Tsui, 1993), also involves
a tandemly repeated 9 bp segment, CAGGAGGCC (posi-
tions 2719^2727 and 2728^2736), which is deleted in EBS-MD
patients with mutation 2719del9, presumably by slipped mispairing
of DNA (Rouan et al, 2000). The intronic variations A
(2436þ13insG) and B (2436þ141del113) are homozygous in the
mother and probands and heterozygous in the father, whereas C
(2437 ^ 10delT) and D (2589þ 6 T4C) are heterozygous in
the father and mother, respectively, and absent in the probands
(Fig 2D). Based on these results, we could conclude that the exo-
nic deletion 2727del14 is the causative mutation associated with
EBS in the probands, and that the intronic variations are intra-
genic polymorphisms, which identify the three PLEC1 alleles in
this family and which do not exert any direct role in the etiology
of the condition.
Presence of mutation 2727del14 in the gDNA of the parents
and the two probands was con¢rmed by restriction enzyme
digestion of gDNA (Fig 2D, bottom panel). Speci¢cally, the muta-
tion 2727del14 abolishes a restriction site for DraIII endonuclease.
Therefore, upon PCR ampli¢cation of a DNA fragment contain-
ing exons 21 and 22, and subsequent enzymatic digestion with
DraIII, agarose gel analysis of the digestion products revealed that
the probands’gDNAwas not digested and yielded a single 592 bp
band. Conversely, digestion of the parents’ DNA resulted in two
additional bands of 523 bp and 83 bp (not visible), which corre-
spond to the restriction digestion of the 606 bp DNA from the
wild-type allele, thus indicating that the parents are heterozygous
for the 2727del14 mutation. Moreover, restriction analysis of 80
PLEC1 alleles in a control population exhibited absence of muta-
tion 2727del14. In conclusion, although several anomalies at the
gDNA level were found in this family, our results clearly demon-
strate that the 2727del14 mutation is causative of the severe EBS
phenotype.
Mutation 2727del14 involves the 30 portion of exon 22 but pre-
serves the ‘‘donor’’ splice site sequence (AG/g) in the mutated plec-
tin pre-mRNA.This deletion is therefore thought to cause an out
of frame shift in the amino acid sequence, which results in a PTC
84 amino acids downstream in exon 24. It is known that PTC
induce rapid decay of abnormal RNA transcripts. In our case, de-
cay of the plectin RNA transcripts is indirectly inferred from the
inability to amplify plectin cDNA sequences by RT-PCRof total
RNA extracted from the probands’ skin samples, and from the
immuno£uorescence studies on the probands’ skin biopsies,
whereby expression of shortened plectin molecules from the
morbid PLEC1 consisting of the ABD and the N-terminal
portion of the globular plakin domain is unlikely (Fig 2E).
Because exon skipping of the internally deleted exon 22, either
alone or with involvement of other downstream exons, cannot
be formally ruled out, however, the possible rescue of mutated
plectin polypeptides carrying in-frame internal deletions was
further investigated and excluded by analysis of all the possible
combinations of legitimate exon skipping in this area of the
PLEC1 gene.
The unusual severity of the condition in our probands, which
at birth presented extracutaneous abnormalities in addition to
skin blistering, may be explained by the fact that mutation
2727del14 is the only genetic defect so far reported that causes
PTC within the plakin globular domain of plectin. Among the
Figure1. Altered expression of plectin in the EBS patients. Immu-
no£uorescence analysis of frozen sections of involved skin samples ob-
tained from proband 2 (a, c, e, g) and fetal skin specimens obtained from
an unrelated control (b, d, f, h) using mAb HD121 (a, b ) speci¢c to human
plectin, 1A8C (c, d ) to the cytoplasmic domain of collagen type XVII,
GoH3 (e, f ) to integrin a6, and CKB1 (g, h) to cytokeratin 14. The upper
panels (horizontal sections) show that, in the proband, immunoreactivity of
plectin is absent in the skin annexes, whereas immunoreactivity to collagen
type XVII and integrin a6 shows slight attenuation of the £uorescent sig-
nal compared to a healthy control. Immunoreactivity to cytokeratin 14 was
normal. In the patient, vertical sections demonstrate that the £oor of the blis-
ters is not reactive to mAb HD121 (a) and has a residual immune reactivity
(arrows) to 1A8C and GoH3 (c, e, respectively) compared to the wild-type
control (b, d, f). Absent immunoreactivity of the involved skin to cytoker-
atin 14 con¢rms that the cleavage plane of the blister lies within the ventral
aspect of the basal keratinocytes (g). Scale bars: 50 mm.
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known genetic mutations associated with EBS-MD all the small
insertions, deletions, and nonsense mutations that cause PTC
localize within the central rod and in the globular C-domains of
plectin, whereas only in-frame insertions or deletions of nucleo-
tides resulting in loss or insertion of amino acids have been found
in the plakin domain (Fig 2E) (Pulkkinen et al, 1996; Takizawa
et al, 1999; Rouan et al, 2000; Bauer et al, 2001).We hypothesize
that the disruptive e¡ect of mutations in the rod and C-terminal
domains of plectin may be partially rescued in speci¢c tissues
either by skipping of the mutated exons or by expression of
extracutaneous truncated or rodless variants of the protein
(Elliott et al, 1997). In contrast, only changes in the amino acid
sequence of the globular plakin domain may preserve some of
the multiple functions of plectin and result in nonlethal forms
of EBS-MD or EBS-O, whereas disruption, either spontaneous
(as in the probands described in this study) or induced (as in plec-
tin nul/nul mice), results in much more severe, life-threatening
forms of the condition.
Mutation 2727del14 brings new insight into the geno-
typephenotype relationship in EBS patients and de¢nes a new
clinical variant of this blistering condition characterized by
in utero onset of skin and developmental abnormalities supected
Figure 2. Identi¢cation of genetic muta-
tion 2727del14. (A) The PCR products from
the ampli¢cation of gDNA including the in-
tronexon boundaries of exons 20^22 were
electrophoresed on a 1% agarose gel together
with DNA molecular weight markers (m).
Compared to a wild-type control (C), the pro-
bands’mother (M) and proband (p) are homo-
zygous for a 113 bp deletion within intron 20,
whereas the probands’ father (F) is heterozy-
gous for this deletion. (B) CSGE heteroduplex
analysis of the PCR product spanning exons
21 and 22 revealed a complex pattern of shifts
in the migrating bands in the mother (M),
father (F), and probands (P1, P2), compared to
the control (C). As the parents are consangui-
neous, and therefore the probands were as-
sumed homozygous for the mutation, CSGE
analysis of the probands was done using PCR
product solely from the probands (P1, P2), and
mixed with an equal quantity of control PCR
product (P1þC, P2þC). (C) Direct nucleo-
tide sequencing of the PCR ampli¢cation
products of the gDNA sequence spanning
exon 22 disclosed the homozygous 14 bp dele-
tion (2727del14) in the two probands, and the
heterozygosity of both parents for this muta-
tion. (D) Genotyping of the gDNA in the
EBS family. Top panel: The intragenic poly-
morphisms identify the three PLEC1 alleles
(1, 2, 3) in the family.The genealogic tree illus-
trates the Mendelian inheritance of mutation
2727del14 in the carriers (half-¢lled) and homo-
zygous members (black) of the nuclear EBS
family. Bottom panel: Mutation 2727del14
abolishes a DraIII restriction site in exon 22.
Digestion of the DNA fragment obtained by
PCR ampli¢cation of exons 21 and 22 gener-
ates two restriction products (523 and 83 bp)
of a 606 bp fragment in healthy unrelated con-
trols (lanes Cc (control digested) and Cu,
control undigested, respectively) and the
heterozygous parents (lanes M, F). The parents
harbour an additional undigested 592 bp band
ampli¢ed from the morbid PLEC1 allele,
which is found as a unique band in the homo-
zygous probands (P1 and P2). (E) Localization
of mutation 2727del14 in plectin. Plectin com-
prises an N-terminal actin-binding domain
(vertical bars) with a short variable sequence up-
stream, a globular plakin-like domain (black), a
central coiled-coil rod domain (horizontal bars),
and a C-terminal intermediate ¢lament-bind-
ing domain (empty circles). The position of mu-
tation 2727del14 with respect to the genetic
mutations so far associated with EBS-MD
and EBS-O (in italics, underlined) is indicated.
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to include obstruction of the gastric outlet. In this respect, screen-
ing for mutations of the cDNA for integrin a6b4, which are
commonly associated with the junctional form of epidermolysis
bullosa with pyloric atresia (PA-JEB, OMIM 226730), excluded
the involvement of this hemidesmosome component in the con-
dition. The similarity between these two forms of epidermolysis
bullosa includes the level of the cleavage plane within the blisters,
which strengthens the notion of hemidesmosomal forms of in-
herited epidermolysis bullosa that arise from genetic mutations
disrupting the assembly of hemidesmosomes (Pulkkinen
and Uitto, 1999). Along with the two other genetic mutations in
unrelated patients, which have been identi¢ed in this area of
the PLEC1 gene, the disclosure of mutation 2727del14 emphasizes
the relevance of exon 22 and that of the adjacent DNA sequences
in the etiology of EBS. The presence of repeated nucleotide
sequences favoring slipped mispairing of DNA may also
account for the multiple polymorphisms identi¢ed in the PLEC1
alleles, which attests to the relative instability of this area in the
genome.
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